AT500370B1 - Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen - Google Patents

Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen Download PDF

Info

Publication number: AT500370B1
Authority: AT; Austria
Prior art keywords: endosulfine; alpha; measurement; alzheimer; diagnosis
Prior art date: 2001-01-22

Application number

AT1082001A

Other languages

English (en)

Other versions

AT500370A1 (de

AT500370B8 (de

Inventor

Gert Dr Lubec

Barbara Dr Lubec

Original Assignee

Red Bull Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-01-22

Filing date

2001-01-22

Publication date

2006-03-15

2001-01-22 Application filed by Red Bull Gmbh filed Critical Red Bull Gmbh

2001-01-22 Priority to AT1082001A priority Critical patent/AT500370B8/de

2005-12-15 Publication of AT500370A1 publication Critical patent/AT500370A1/de

2006-03-15 Publication of AT500370B1 publication Critical patent/AT500370B1/de

2007-02-15 Application granted granted Critical

2007-02-15 Publication of AT500370B8 publication Critical patent/AT500370B8/de

Links

102000008110 endosulfine Human genes 0.000 title abstract 3
108010074629 endosulfine Proteins 0.000 title abstract 3
238000005259 measurement Methods 0.000 title abstract 2
230000000626 neurodegenerative effect Effects 0.000 title abstract 2
208000024827 Alzheimer disease Diseases 0.000 title 1
238000003745 diagnosis Methods 0.000 title 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
210000005013 brain tissue Anatomy 0.000 abstract 1
210000001638 cerebellum Anatomy 0.000 abstract 1
210000002216 heart Anatomy 0.000 abstract 1
210000003734 kidney Anatomy 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
210000004185 liver Anatomy 0.000 abstract 1
210000002751 lymph Anatomy 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
210000000056 organ Anatomy 0.000 abstract 1
230000002093 peripheral effect Effects 0.000 abstract 1
210000002381 plasma Anatomy 0.000 abstract 1
210000002966 serum Anatomy 0.000 abstract 1
210000001519 tissue Anatomy 0.000 abstract 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)

AT1082001A 2001-01-22 2001-01-22 Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen AT500370B8 (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AT1082001A AT500370B8 (de)	2001-01-22	2001-01-22	Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
AT1082001A AT500370B8 (de)	2001-01-22	2001-01-22	Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen

Publications (3)

Publication Number	Publication Date
AT500370A1 AT500370A1 (de)	2005-12-15
AT500370B1 true AT500370B1 (de)	2006-03-15
AT500370B8 AT500370B8 (de)	2007-02-15

Family

ID=35474670

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT1082001A AT500370B8 (de)	2001-01-22	2001-01-22	Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen

Country Status (1)

Country	Link
AT (1)	AT500370B8 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998030692A2 (en) *	1997-01-07	1998-07-16	Abbott Laboratories	Human endosulfine gene
WO2000037483A1 (en) *	1998-12-22	2000-06-29	Myriad Genetics, Inc.	Protein-protein interactions in neurodegenerative disorders

2001
- 2001-01-22 AT AT1082001A patent/AT500370B8/de not_active IP Right Cessation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998030692A2 (en) *	1997-01-07	1998-07-16	Abbott Laboratories	Human endosulfine gene
WO2000037483A1 (en) *	1998-12-22	2000-06-29	Myriad Genetics, Inc.	Protein-protein interactions in neurodegenerative disorders

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
C.A. 117 (15) 1992: 144256V C.A. 124 (21) 1996: 283592J *
C.A. 125 (17) 1996: 213654C C.A. 129 (15) 1998: 187171D *
C.A. 131 (23) 1999: 307201D C.A. 132 (3) 2000: 19382S *
C.A. 134 (15) 2001: 202724K *

Also Published As

Publication number	Publication date
AT500370A1 (de)	2005-12-15
AT500370B8 (de)	2007-02-15

Similar Documents

Publication	Publication Date	Title
EP2306192A3 (de)	2011-08-10	Risikomarker für eine Herzkreislaufkrankheit
WO2002027326A3 (en)	2002-08-22	Method and kit for the transderaml determination of analyte concentration in blood
WO2007007129A3 (en)	2007-05-31	Diagnostic method for brain damage-related disorders
WO2005108989A3 (en)	2006-06-01	Assay for antibodies
NO20050186L (no)	2005-03-10	Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser
Laakso et al.	1996	MR T2 relaxometry in Alzheimer's disease and age-associated memory impairment
WO2004046729A3 (en)	2004-07-22	Bodily fluid markers of tissue hypoxia
DE60239407D1 (de)	2011-04-21	Okulare diagnose der alzheimer-krankheit
WO2006134390A3 (en)	2007-04-19	Method for diagnosing neurodegenerative disease
DE502005007863D1 (de)	2009-09-17	P1gf und flt-1 als prognostische parameter bei kardiovaskulären erkrankungen
Yoshida et al.	2015	Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine
DE69431016D1 (de)	2002-08-29	Verfahren zur "In-vivo"-Messung der Konzentration von xenobiotischen Verbindungen mittels magnetischer Kernresonanz
Puy et al.	2016	Interactions between flow oscillations and biochemical parameters in the cerebrospinal fluid
JP2008532033A (ja)	2008-08-14	自閉症や脳性麻痺などの精神疾患の予後判定方法
AU2003259222A1 (en)	2004-02-16	Method of diagnosing alzheimer's disease
WO2005098433A3 (en)	2006-12-28	Diagnostic assays for alzheimer’s disease
DE60232595D1 (de)	2009-07-23	Methode zur diagnose von nierenerkrankungen
WO2003049604A3 (en)	2004-02-12	Method for mr/nmr imaging
EP1476757A4 (de)	2006-04-26	Verfahren und kit zur krebsvorhersage
AT500370B1 (de)	2006-03-15	Verfahren zum diagnostizieren, verhindern und behandeln neurodegenerativer erkrankungen
EP1729129B1 (de)	2013-05-29	Verfahren zur diagnose einesapoplektischen schlaganfalls/asymptomatischen hirninfarkts unter verwendungvon polyamin- und acroleingehalten, polyaminoxidase-aktivität oder deren proteingehaltals indikatoren
WO2001038581A3 (en)	2002-03-14	Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
RU2008101419A (ru)	2009-07-20	Способы диагностики и лечения цереброваскулярных явлений на основе пептидов nr2
EP1356299B1 (de)	2006-04-19	Verfahren zur diagnose der alzheimerschen krankheit
Kim et al.	2016	Reference intervals for plasma amyloid β in korean adults without cognitive impairment

Legal Events

Date	Code	Title	Description
2010-10-15	ELJ	Ceased due to non-payment of the annual fee